Company Profiles

driven by the PitchBook Platform

Aegle Therpeutics

Aegle Therpeutics
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of therapeutic products based on micro-vesicle isolation technology. The company specializes in the development of regenerative medicines based on extracellular vesicle isolation technology that are used to treat burns and chronic wounds as well as orthopedic injury, cardiovascular disease and certain rare diseases.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
1951 North West 7th Avenue
Suite 150
Miami, FL 33136
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aegle Therpeutics’s full profile, request a free trial.

Aegle Therpeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Aegle Therpeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0

You’re viewing 1 of 1 investors.

Aegle Therpeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Shelley Hartman Chief Executive Officer, Board Member & Co-Founder
Robert Williamson Jr. Co-Founder & Chief Financial Officer
Evangelos Badiavas MD Co-Founder & Chief Scientific Officer
Stephen Davis Co-Founder & Board Member

You’re viewing 4 of 4 executives.

Aegle Therpeutics Board Members (2)

Name Representing Role Since Contact
Info
Robert Williamson III Self Board Member 000 0000
Stephen Davis Aegle Therpeutics Co-Founder & Board Member 000 0000

You’re viewing 2 of 2 board members.